GLP-1 Weight Loss Drugs May Lower the Risk for 14 Obesity-Related Cancers
A new study finds women taking GLP-1 Receptor agonists were significantly less likely to develop obesity-related cancers.
Health News is provided as a service to Jomici Apothecary site users by HealthDay. Jomici Apothecary nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.